Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19).
Autor: | Mancebo G; Department of Obstetrics and Gynecology, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain GMancebo@parcdesalutmar.cat., Solé-Sedeño JM; Department of Obstetrics and Gynecology, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain., Membrive I; Department of Radiation Oncology, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain., Taus A; Department of Medical Oncology, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain., Castells M; Department of Obstetrics and Gynecology, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain., Serrano L; Department of Pathology, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain., Carreras R; Department of Obstetrics and Gynecology, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain., Miralpeix E; Department of Obstetrics and Gynecology, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain. |
---|---|
Jazyk: | angličtina |
Zdroj: | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2021 Jun; Vol. 31 (6), pp. 914-919. Date of Electronic Publication: 2020 Oct 05. |
DOI: | 10.1136/ijgc-2020-001942 |
Abstrakt: | The SARS-CoV-2 (COVID-19) pandemic has significantly impacted the management of patients with gynecologic cancers. Many centers have reduced access to routine visits to avoid crowded waiting areas and specially to reduce the infection risk for oncologic patients. The goal of this review is to propose a surveillance algorithm for patients with gynecologic cancers during the COVID-19 pandemic based on existing evidence and established guidelines. It is time to consider strategies based on telemedicine and to adapt protocols in this new era. We hereby propose a strategy for routine surveillance both during and beyond the pandemic. Competing Interests: Competing interests: None declared. (© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.) |
Databáze: | MEDLINE |
Externí odkaz: |